Confidia says early EBOO patients report more energy and faster recovery

By AI, Created 5:22 PM UTC, May 18, 2026, /AGP/ – Confidia Health Institute says early patient feedback from its Bristol, Connecticut, location suggests Extracorporeal Blood Oxygenation and Ozonation may help people dealing with fatigue, post-viral symptoms and inflammation-related conditions. The clinic is pairing patient-reported changes with biomarker tracking as it folds EBOO into broader care plans.

Why it matters: - Confidia Health Institute is positioning EBOO as a support therapy for patients with complex, multi-system health concerns. - The Bristol, Connecticut, rollout targets symptoms that often affect daily functioning, including chronic fatigue, post-viral issues and inflammation-related conditions. - The clinic is also trying to match how patients feel with measurable changes over time, which could help guide future care plans.

What happened: - Confidia Health Institute shared early clinical observations after introducing Extracorporeal Blood Oxygenation and Ozonation, or EBOO, at its Bristol location. - Clinicians say interest is growing among patients looking for help with chronic fatigue, post-viral symptoms and inflammation-related conditions. - Dr. Kevin Greene, Confidia’s founder, said the goal is to support the body’s ability to regulate, recover and function more efficiently over time. - A patient said the difference became noticeable after the third treatment, with easier breathing and more energy over time. - The same patient said the therapy became one of the most impactful parts of the health journey after initial skepticism.

The details: - Confidia says it is tracking patient experience alongside biomarker data to better understand responses to treatment. - EBOO is used as part of a broader integrative care model at Confidia. - Dr. Greene said therapies like EBOO may support how the body responds to other treatments and improve overall effectiveness as part of a broader care plan. - Dr. Greene also said many patients appear to be carrying a higher burden from environmental and metabolic stressors than previously understood. - EBOO therapy is available by appointment at Confidia Health Institute’s Bristol office. - Patients can learn more or schedule a consultation by calling (860) 378-2891 or visiting ConfidiaHealthInstitute.com/eboo. - Confidia Health Institute operates primary care and advanced health offices in Bristol and Plantsville, Connecticut. - Confidia’s programs include MetaLab, a metabolic testing and longevity lab, and Confidia Advanced Wound Specialists, an advanced wound care and general surgery program.

Between the lines: - The messaging blends patient anecdotes with clinical monitoring, which suggests Confidia wants EBOO viewed as both an experiential and data-informed therapy. - The emphasis on broader stressors and multi-system concerns signals a focus on chronic, hard-to-treat conditions rather than one symptom at a time. - The release does not present controlled trial data, so the reported benefits should be read as early observations rather than proven outcomes.

What’s next: - Confidia plans to continue following patient-reported outcomes alongside biomarkers as more people use EBOO. - The Bristol office is the current access point for appointments, which suggests the clinic is still in an early phase of rollout. - Future updates will likely depend on whether the clinic sees consistent patterns in symptom relief and measurable change over time.

The bottom line: - Confidia is using early patient feedback to build momentum around EBOO while it looks for clearer clinical signals in everyday care.